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≥500 mg/g, respectively). In addition, European-ancestry PediGFR patients (cases) were compared with 1347 European-ancestry children without kidney disease (controls) to identify
genetic variants associated with the presence of CKD.
Results. SNPs with suggestive association P-values <1×10−5
were identiﬁed in 10 regions for eGFRcrea, four regions for proteinuria and six regions for CKD including some plausible biological candidates. No SNP was associated at genome-wide
signiﬁcance (P < 5×10−8). Investigation of the candidate
genes for proteinuria in adults from the general population provided support for a region on chromosome 15 near RSL24D1/
UNC13C/RAB27A. Conversely, targeted investigation of genes
harboring GFR-associated variants in adults from the general
population did not reveal signiﬁcantly associated SNPs in children with CKD.
Conclusions. Our ﬁndings suggest that larger collaborative efforts will be needed to draw reliable conclusions about the presence and identity of common variants associated with eGFR,
proteinuria and CKD in pediatric populations.

A B S T R AC T
Background. Chronic kidney disease (CKD) in children is
characterized by rapid progression and a high incidence of
end-stage renal disease and therefore constitutes an important
health problem. While unbiased genetic screens have identiﬁed
common risk variants inﬂuencing renal function and CKD in
adults, the presence and identity of such variants in pediatric
CKD are unknown.
Methods. The international Pediatric Investigation for Genetic
Factors Linked with Renal Progression (PediGFR) Consortium
comprises three pediatric CKD cohorts: Chronic Kidney Disease in Children (CKiD), Effect of Strict Blood Pressure Control
and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) and Cardiovascular Comorbidity in Children
with CKD (4C). Clean genotype data from >10 million genotyped or imputed single-nucleotide polymorphisms (SNPs)
were available for 1136 patients with measurements of serum
creatinine at study enrolment. Genome-wide association studies were conducted to relate the SNPs to creatinine-based estimated glomerular ﬁltration rate (eGFRcrea) and proteinuria
(urinary albumin- or protein-to-creatinine ratio ≥300 and
© The Author 2015. Published by Oxford University Press
on behalf of ERA-EDTA. All rights reserved.
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INTRODUCTION

M AT E R I A L S A N D M E T H O D S
The PediGFR Consortium is an international collaborative effort to identify genetic risk factors for kidney disease. The
Chronic Kidney Disease in Children (CKiD) prospective cohort
study [21] enrolled 540 children aged 1–16 years with an estimated GFR (eGFR) of 30–75 mL/min/1.73 m2, 440 of which
were genotyped. The Effect of Strict Blood Pressure Control
and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) trial recruited 468 children. Of these, 315 children aged from 3–18 years and with an eGFR of 15–80 mL/min/
1.73 m2 at the baseline visit were genotyped [22]. The Cardiovascular Comorbidity in Children with CKD (4C) prospective
study enrolled 705 children aged 6–17 years with an initial
eGFR of 10–45 mL/min/1.73 m2 [23], 691 of whom were
genotyped.
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Chronic kidney disease (CKD) is an important global health
problem [1]. Although uncommon in children [2–4], CKD in
this population is associated with increased risk for poor
growth, cardiovascular disease and mortality [5–7]. Despite
the lower prevalence of CKD in children when compared
with adults, a higher proportion of pediatric CKD patients progress to end-stage renal disease. The average life expectancy of
children with renal replacement therapy (RRT) is 63 years for
those receiving a transplant and only 38 years for those remaining on dialysis [8].
Thus, gaining insights into pathophysiological mechanisms
that underlie the development and progression of pediatric
CKD is of great importance. Previous studies in adults support
a genetic component to CKD and kidney function that is also
observed in individuals from the general population without
clear monogenic causes of CKD [9–11]. Genome-wide association studies (GWAS) were used successfully to identify common genetic variants associated with measures of renal
function and CKD in population-based studies [12–17] as
well as with speciﬁc kidney diseases such as IgA nephropathy
[18, 19] and membranous nephropathy [20].
Previous GWAS of CKD and renal function measures were
conducted among middle-aged or older adults. It is unclear
whether common genetic variants also contribute to CKD
risk in children. While monogenic causes account for a substantial fraction of pediatric CKD, it is conceivable that common
genetic variants, each typically conferring small increases in
risk, contribute to the development and/or progression of
CKD. To date, no pediatric GWAS of renal function parameters
have been conducted because of the lack of sufﬁciently large
study populations. The Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) Consortium has
now assembled several pediatric CKD cohorts. Here we report
on GWAS utilizing baseline parameters of renal function, glomerular ﬁltration rate (GFR) and proteinuria and CKD from data
of 1136 PediGFR participants.

Publicly available data from the Study of the Genetic Causes
of Complex Pediatric Disorders [24] from the Children’s Hospital of Philadelphia (CHOP) were obtained [database of Genotypes and Phenotypes (dbGAP) accession number phs000490.
v1.p1] and used as an external control population (interquartile
age range 6–17 years). Patients with kidney-related diseases (n
= 41) were excluded based on primary diagnosis International
Classiﬁcation of Diseases, Ninth Revision codes (580–594, 598,
403, 404, 250.4 and 753).
GFR was estimated using equations by Schwartz et al. [25]:
eGFRcrea ¼ 42:3  ðheight½m=serum creatinine[mg/dlÞ0:78 Þ and
eGFRcycr ¼ 41:6  ðheight½m=serum creatinine½mg=dlÞ0:443 
ð1:8=serum cystatin C ½mg/dlÞ0:479 Þ. Iohexol GFR was measured for the CKiD cohort [21]. Proteinuria was deﬁned as a
urinary albumin-to-creatinine ratio (UACR) ≥300 mg/g or
urinary protein-to-creatinine ratio (UPCR) ≥500 mg/g. We
chose to analyze proteinuria as a binary phenotype because of
its clinical relevance and its high prevalence in CKD populations,
and to minimize an effect of medication intake that may result in
smaller alterations in the UACR/UPCR on a continuous scale.
For the case–control analyses, all PediGFR patients were
treated as CKD cases, while CHOP children without kidney disease were treated as controls.
Using the Illumina Inﬁnium 2.5M-8 microarray, 1450 PediGFR participants were successfully genotyped at ∼2.4 million
single-nucleotide polymorphism (SNP) markers. Data cleaning
was performed according to standard protocols [26] separately
for ESCAPE/4C and for CKiD and resulted in exclusion of n =
84 samples (Supplementary data, Figure S1).
Genomic ancestry was assessed by principal component
analysis using Eigensoft SmartPCA v4.2 [27]. The CEU,
CHB/JPT and YRI groups (HapMap phase 3, release 2) were
used as reference populations to visually derive ancestryspeciﬁc clusters (Supplementary data, Figure S2). Participants
were assigned to ﬁve groups of sufﬁcient size for analysis
[CKiD European Ancestry (n = 262), ESCAPE Central European (n = 223), ESCAPE Turkish (n = 62), 4C Central European (n = 270) and 4C Turkish (n = 341)].
Genotyped markers were removed when their call rate was
<95%, yielding an average of 1.7 million remaining markers
per group. Subsequently, genotype imputation was performed
according to standard protocols [28] separately for each group
using SHAPEIT v2.r644 [29] and IMPUTE2 v2.3.0 [30].
Phased haplotypes from the 1000 Genomes project [31]
(Phase 1, release v3 date 2012-04-19, ALL subset) were used
as the reference panel. After imputation, ∼10.5 million SNPs
of high imputation quality (information measure ≥0.8) were retained in each group.
A ﬂow chart outlining data preparation for the analyses
using the external control population is presented in the Supplementary data (Figure S3). Control samples had been genotyped on the Illumina Human 610-Quad v1 (n = 1480) and
the Illumina Human Hap550 v3 arrays (n = 1151). Genotype
datasets of only European-ancestry PediGFR cases and
CHOP controls were merged. Based on the top 20 calculated
principal components, 2005 individuals of similar genetic ancestry were retained for analyses (658 cases, 1347 controls; Supplementary data, Figure S4). Because of the different
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genotyping arrays and data sources, stringent data cleaning was
performed prior to imputation, removing SNPs with minor allele frequency (MAF) <1%, Hardy–Weinberg equilibrium
(HWE) P-value <0.01 (in cases and controls separately) and
call rate <95%. Imputation of the combined case–control dataset with the same settings as outlined above resulted in 8.3 million high-quality SNPs (information measure ≥0.8).
Genome-wide association tests were performed using
SNPtest v2.5 [32]. Within each of the ﬁve PediGFR groups, a
linear regression model was used to relate continuous eGFR
(ln transformed) to each SNP using an additive model and
genotype dosages. The analysis for the binary outcome proteinuria among the PediGFR children was performed similarly
using logistic regression. We adjusted for sex, age and any of
the ﬁrst 10 principal components associated with the analyzed
phenotype (P < 0.05).
A ﬁxed-effects inverse-variance weighted meta-analysis
combined estimates across the ﬁve groups using the software
GWAMA [33]. Only SNPs with MAF >1% and present in
>50 individuals in each group were meta-analyzed. Data were
combined over all ﬁve groups (n = 1136) and separately for individuals of central European ancestry (n = 744) and Turkish
ancestry (n = 397). Genomic control was applied at the individual study level and post meta-analysis [34]. A P-value threshold
<1×10−5 was used to indicate suggestive signals and <5×10−8 to
indicate genome-wide signiﬁcance.
For the comparison of PediGFR cases with external controls,
power calculations using Quanto 1.2.4 showed that, for a discovery subset of 658 cases and 2 controls per case, there was
at least 80% power to detect a CKD odds ratio of 1.87 (1.57)
or higher at genome-wide signiﬁcance at a MAF of 10%
(30%), assuming a population prevalence of pediatric CKD of
0.01%. A logistic regression model was used to relate CKD or
proteinuria case status to each SNP using an additive model
with covariates as described above.
Experimental follow-up was attempted for novel genomewide signiﬁcant signals and genes in loci suggestively associated
with the clinically important phenotype proteinuria. For genes
in the linkage disequilibrium (LD) block of the index SNP, relevant orthologs in Danio rerio, including all paralogs, were identiﬁed. All animal work was carried out according to relevant
national and international guidelines. Zebraﬁsh of the strain
AB/TL wild-type were maintained, and the embryos were
staged as previously described [35].
Zebraﬁsh orthologs were identiﬁed for clmp, gramd1b,
rab27a and rsl24d1. SAMD3 had no ortholog; the extended
LD block containing FAM151B contained too many genes to
make experimental follow-up feasible. Ampliﬁcation was carried out from zebraﬁsh cDNA with speciﬁc primers, cloned
into TOPO (Invitrogen) and linearized with corresponding restriction enzymes. Whole-mount in situ hybridization (WISH)
analysis using digoxigenin-labeled probes was performed as described [36] using 4-Nitro blue tetrazolium chloride (blue)
(Roche) as substrate.
In order to evaluate the presence of risk variants in genes
previously associated with the complex traits CKD, eGFR, creatinine and/or cystatin C levels in adults, a list of 34 genes was
assembled using the NHGRI GWAS Catalog [37]
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(Supplementary data, Table S1). For each of these genes plus
a 5 kb ﬂanking region, the SNP of MAF >5% with the lowest
P-value was retrieved from the PediGFR meta-analysis data
for the corresponding phenotype. To correct for multiple testing, a Bonferroni correction for the number of independent
SNPs per gene (determined using a pruning procedure of the
1000 Genomes Project EUR data; r2 <0.2, window size 50 bp,
offset 5 bp) and the number of investigated genes was used.
We further investigated the genes implicated by the PedGFR
data in the Chronic Renal Insufﬁciency Cohort (CRIC) study
[38], a study of adult patients with CKD. Data were acquired
from dbGAP (accession number phs000524.v1.p1). PediGFR
candidate genes were queried in CRIC baseline eGFR association data in the subsample of patients of European ancestry
without diabetes (n = 926).
In addition, we queried PediGFR proteinuria-associated regions for their association with the UACR in data from up to 54
450 mostly population-based adults studied in the CKDGen
Consortium ([14] and personal communication). Signiﬁcance
thresholds were derived based on the number of independent
SNPs in the region as described above. Lastly, we investigated
the expression of these genes in publicly available data from
freshly isolated murine podocytes and other glomerular cells
[39]. Differences in gene expression between podocytes and
other glomerular cells were corrected for transcriptome-wide
multiple testing and additionally for the number of regions investigated (n = 4).

R E S U LT S
Demographic parameters were similar across the three PedGFR
cohorts (Table 1). Differences in baseline GFR, serum creatinine and cystatin C as well as the proportion of proteinuric children were consistent with differences in study-speciﬁc inclusion
criteria.
GWAS of eGFR in PediGFR participants
Association analyses of eGFRcrea showed no evidence for
systematic inﬂation of results in the individual groups (1.00 <
λ < 1.02) or after meta-analysis (λ = 1.01; Figure 1A). While
10 genomic regions contained at least one SNP associated
Table 1. Characteristics of the PediGFR study cohorts

Subjects (n)
Sex (female) (%)
Age (years)
Height (cm)
Weight (kg)
Creatinine (mg/dl)
Cystatin C (mg/l)
eGFR (creatinine) (ml/min)
eGFR (cystatin C/creatinine)
(ml/min)
iGFR (iohexol measured) (ml/
min)
Proteinuria/albuminuriaa (%)
a

CKiD

ESCAPE 4C

All

262
36
11 ± 4
136 ± 27
37 ± 19
1.4 ± 0.7
1.8 ± 0.6
46 ± 15
46 ± 15

285
44
12 ± 4
143 ± 23
39 ± 18
2.1 ± 1.3
2.5 ± 0.9
37 ± 14
35 ± 12

611
35
12 ± 3
140 ± 20
38 ± 16
2.6 ± 1.4
2.9 ± 0.9
30 ± 11
29 ± 11

1158
37
12 ± 4
140 ± 23
38 ± 17
2.2 ± 1.3
2.5 ± 0.9
36 ± 15
34 ± 15

45 ± 16

–

–

–

40

55

52

53

UACR >300 mg/g or UPCR >0.5 g/g.
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with eGFRcrea at P < 10−5, none of these loci reached genomewide signiﬁcance. Table 2 shows the SNP with the lowest
P-value (index SNP) at each of the loci. Regional association
plots of the associated regions are shown in the Supplementary
data.
To assess whether the association with creatinine-based
eGFR reﬂected an association with kidney function rather
than with creatinine metabolism, we assessed the association
of the index SNPs with an alternative estimate of GFR,
eGFRcycr. Both effect sizes and directions of association were
consistent (Supplementary data, Table S2). Second, measured
iohexol GFR was available in a subset of CKiD study participants. Again, the effects of the index SNPs were consistent
with those found in the main analysis (Figure 2), indicating

the use of eGFRcrea as the primary phenotype was appropriate.
Allele frequencies of the index SNPs were similar across the ﬁve
groups.
In the secondary meta-analyses of the three groups of central
European ancestry and the two groups of Turkish ancestry separately, there were also no genome-wide signiﬁcant ﬁndings for
eGFRcrea (Supplementary data, Table S3).
GWAS of proteinuria in PediGFR
In association analyses comparing PediGFR children with
proteinuria with PediGFR children without proteinuria, we observed no evidence for systematic inﬂation of study-speciﬁc or
combined results (Figure 1B). Four genomic regions contained
index SNPs of MAF ≥5% and P < 10−5, mapping in or near

ORIGINAL ARTICLE
F I G U R E 1 : (A) Quantile–quantile (QQ) plots for the PediGFR eGFRcrea quantitative GWAS and (B) the PediGFR proteinuria GWAS. X-axis,
expected −log10 P-value; Y-axis, observed −log10 P-value. Thin lines above and below the identity line indicate the 95% conﬁdence interval.

Table 2. SNPs associated with eGFR or proteinuria with P < 10-5 in the PediGFR Consortium
SNP identiﬁer

Chr.

eGFR (creatinine) (n = 1136)
rs7541937
1
rs71413769
2
rs10928150
2
rs138904061
3
rs10054413
5
rs62441014
7
rs11066679
12
rs12898179
14
rs344364
16
rs6036759
20
Proteinuria (n = 1065)
rs145768835
5
rs61201007
6
rs55847827
11
rs76158983
15

Pos.

Coded
allele

Coded allele
frequency

35341982
139833140
143254723
105174202
88605629
5533319
114123402
67964171
1973516
2491209

G
G
A
C
G
C
C
C
A
A

0.47
0.10
0.46
0.16
0.14
0.41
0.23
0.79
0.22
0.41

79834287
130515494
123189003
55309006

C
T
G
A

0.18
0.37
0.18
0.05

Effect/OR

SE/95% CI

Effect
−0.07
0.11
−0.07
−0.09
−0.10
0.07
−0.08
−0.08
0.08
0.07
OR
0.55
1.54
1.80
0.35

SE
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.01
95% CI
0.42–0.71
1.27–1.87
1.39–2.32
0.22–0.55

P-value

I2

Gene symbols

3.5E-06
4.7E-06
7.3E-06
6.1E-06
7.0E-06
3.9E-06
2.8E-06
8.8E-06
5.0E-06
2.4E-06

0.36
0.01
0.00
0.10
0.23
0.24
0.00
0.00
0.00
0.00

DLGAP3
NXPH2
LRP1B, KYNU
ALCAM
MEF2C
FBXL18
RBM19, LHX5
TMEM229B
HS3ST6, MSRB1
ZNF343, TMC2

6.7E-06
9.3E-06
6.8E-06
5.2E-06

0.00
0.02
0.00
0.00

FAM151B
SAMD3
MIR4493, CLMP
RSL24D1, UNC13C

Variants are ﬁltered for MAF >5% and I2 <50% and must be present in all ﬁve analysis samples. Underlined gene names indicated intronic localization of the SNPs.
Chr., chromosome; Pos., position; OR, odds ratio; SE, standard error; 95% CI, 95% conﬁdence interval. Positions refer to build 37.
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FAM151B, SAMD3, MIR4493/CLMP and RSL24D1/UNC13C/
RAB27A (Table 2), but none of these associations reached
genome-wide signiﬁcance.

associations for both analyses, six regions contained index
SNPs associated with CKD at P < 10−5 and 10 regions contained
such SNPs for proteinuria.

GWAS of CKD and proteinuria comparing PediGFR cases
with external pediatric controls
In order to test for the presence of common genetic variants
associated with the presence of CKD or proteinuria, we compared PediGFR cases with external pediatric controls without
kidney disease. There was no systematic inﬂation of results
comparing PediGFR participants (CKD cases) versus CHOP
controls (λ = 1.03) and for the comparison of PediGFR patients
with proteinuria versus CHOP controls (λ = 1.00). Table 3
shows that while there were no genome-wide signiﬁcant

Experimental evaluation of results
In lieu of suitable and sufﬁciently powered pediatric replication cohorts, we sought experimental evidence and examined
kidney-speciﬁc expression during zebraﬁsh development.
Genes in regions suggestively associated with proteinuria were
selected because of the clinical relevance of proteinuria in CKD
progression. None of the selected genes showed speciﬁc glomerular expression during zebraﬁsh development (Supplementary data, Figure S5), although general expression was
observed for genes clmp, gramd1b, rab27a and rsl24dl.
Among other organ systems, rab27a showed expression in the
pronephric tubule.

F I G U R E 2 : Scatter plot comparing the effects of the index SNPs

associated with eGFRcrea with their effects on iohexol-measured GFR
(iGFR) in a subsample of CKiD patients with measured GFR. Black:
regression line.

Candidate gene evaluation
Finally, we used evidence from studies of CKD or complex
renal traits in adults to examine overlap with the loci implicated
here. None of the 34 known risk genes for CKD or complex
renal traits in adults contained SNPs signiﬁcantly associated
with the corresponding traits in the PediGFR or the
PediGFR-CHOP datasets after correcting for multiple testing.
Some nominally signiﬁcant associations, such as rs11097415
in the SHROOM3 region and CKD, were observed (P =
7.3×10−4). In addition, we queried the 10 genes associated
with eGFR in PediGFR (Table 2) in eGFR association results
of the CRIC baseline data, a study of adult patients with
CKD. Again, the search did not yield any signiﬁcantly associated SNPs.
One of the four candidate regions for proteinuria, RSL24D1/
UNC13C/RAB27A, contained SNPs signiﬁcantly associated with
UACR in the CKDGen dataset. The index SNP in the CKDGen
Consortium was rs1528472 (P = 5×10−7). This variant falls into

Table 3. SNPs associated with CKD with P < 10-5 (European-ancestry PediGFR patients as cases and CHOP children without kidney disease as controls)
SNP identiﬁer

Chr.

Pos.

CKD (n = 2005, n = 658 cases), λ = 1.03
rs13072153
3
123178132
chr5:54032778:I
5
54032778
rs7129190
11
113818752
rs9535020
13
48923808
rs6497441
16
9829848
rs8117834
20
8090640
Proteinuria (n = 1641, n = 294 cases), λ = 1.00
rs792064
2
5518678
rs11720887
3
20940843
rs11011653
10
20163993
rs4963124
11
762791
chr11:87335171:D
11
87335171
rs78057470
15
84149984
rs35219335
17
10077836
rs9895232
17
4519139
rs12601558
17
80179147
rs56052703
19
13432940

Coded
allele

Coded allele
frequency

OR

95% CI

P-value

Gene symbols

G
CT
A
G
T
T

0.38
0.53
0.53
0.13
0.29
0.14

0.70
0.70
0.71
1.69
1.44
1.68

0.60–0.81
0.60–0.81
0.62–0.83
1.35–2.10
1.23–1.69
1.34–2.10

2.6E-06
2.0E-06
4.9E-06
4.2E-06
5.2E-06
5.6E-06

ADCY5, PTPLB
(SNX18, ESM1)
HTR3B, HTR3A
RB1
GRIN2A
PLCB1, TMX4

T
A
G
C
G
C
T
C
C
C

0.42
0.13
0.34
0.71
0.33
0.32
0.14
0.35
0.22
0.34

1.64
1.87
0.59
1.71
0.60
1.61
0.49
1.62
0.56
0.60

1.33–2.01
1.44–2.43
0.47–0.74
1.34–2.18
0.48–0.76
1.31–1.98
0.35–0.67
1.32–1.99
0.43–0.73
0.48–0.75

2.0E-06
4.0E-06
1.4E-06
8.6E-06
9.0E-06
6.6E-06
4.1E-06
2.7E-06
5.5E-06
3.4E-06

SOX11
(VENTXP7)
PLXDC2
TALDO1
TMEM135, RAB38
SH3GL3
GAS7
SMTNL2, ALOX15
CCDC57, SLC16A3
CACNA1A

Variants are ﬁltered to remove SNPs with HWE P-value <0.01 and MAF <10%. Underlined gene names indicate intronic localization of the SNP. OR refers to the effect of each additional
copy of the coded allele.
Chr., chromosome; Pos., position; OR, odds ratio; 95% CI, 95% conﬁdence interval.
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the same LD block as the PediGFR index variant rs76158983,
which was not present in the HapMap-imputation-based
CKDGen data that also did not contain a good proxy (r2 > 0.8)
for rs76158983.
One of the genes, FAM151B, showed signiﬁcantly higher expression in podocytes compared with other glomerular cells in
the murine glomerular expression dataset (1.4-fold change,
corrected P = 3×10−4).
Supplementary data Table S5 summarizes results attempting
to prioritize genes in the implicated regions through several bioinformatics resources that leverage information on gene expression and functional variant annotation as well as a literature
search.

DISCUSSION
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This study is the ﬁrst GWAS meta-analysis based on data from
1136 children with CKD recruited in large international collaborations. Our analyses revealed suggestive associations of several common genetic variants with eGFR and proteinuria as
well as with CKD status at study baseline. However, none of
the associations reached genome-wide signiﬁcance.
Multiple GWASs among adults from the general population
identiﬁed common risk variants associated with measures of
kidney function and CKD [12–17, 40]. The variants identiﬁed
in these studies confer modest effects, as evidenced by the large
sample sizes required for their identiﬁcation. For example,
GWASs among ∼20 000 adults identiﬁed SNPs in four
eGFR-associated regions [12], whereas almost 70 000 individuals were required to identify 25 such regions [13].
Consequently, genetic studies in 1136 children would only
be able to identify common risk variants if they conferred larger
risks than those observed in population-based adults. It is conceivable that a given susceptibility variant may exert a larger effect in children because additional factors, e.g. the presence of
micro- and macro-vascular diseases and of lifestyle-related factors such as smoking and obesity, can be assumed to have a
smaller impact. In support, a previous study of growth and
height reported a larger effect of the same common variant in
children compared with adults [41]. Our results do not support
the presence of common variants of large effect associated with
GFR or proteinuria in this sample of children, since our study
had >85% power to detect, for a variant with MAF of 20%, a
change in average GFR ≥16% or an odds ratio for CKD ≥1.7
per risk allele at genome-wide signiﬁcance.
There are at least three potential explanations for the negative
ﬁndings at genome-wide signiﬁcance: ﬁrst, common genetic susceptibility variants may be present in children but only confer
small changes in risk, similar to adults. This is supported by published GWASs of other phenotypes in pediatric populations that
reported mostly small effect sizes of signiﬁcant and replicated results [24, 42, 43]. The discovery of such variants in children with
CKD would require a larger study sample than PediGFR, and additional samples for replication. This represents a considerable challenge in light of the low incidence of pediatric CKD and the fact
that PediGFR already represents the currently largest international
effort collecting patients across continents for more than a decade.

A second explanation could be that the genetic architecture
of CKD differs between children and adults, and that common
genetic variants of moderate effect do not play an equally important role in children as they do in adults. The substantial
fraction of children with CKD due to a single-gene mutation
[44–46] may limit the role of common genetic variants that
modify rather than determine disease. As GWASs, by design,
do not allow for the detection of single-gene mutations, and because for many children in PediGFR, monogenic causes of
CKD were not comprehensively evaluated, this explanation represents a hypothesis that can be addressed in the future once
whole genome sequences are available.
Third, the general phenotypes studied in PediGFR arise as a
result of different underlying diseases. It is plausible that this
etiologic heterogeneity complicates the detection of causespeciﬁc common variants of larger effect. The combined
study of renal function parameters and CKD in all individuals
was performed to increase statistical power for the discovery of
variants that impact pathophysiological mechanisms irrespective of disease etiology. Evidence from studies in adults with
CKD suggests that common variants of large effects indeed
exist for speciﬁc renal diseases, for example, membranous nephropathy [20] or APOL1-related kidney disease [47]. Again,
given the low incidence of pediatric CKD, subgroup analyses
will be extremely challenging.
Since there were no regions associated at genome-wide signiﬁcance and suggestive regions could not be replicated because of
the lack of adequate studies, we refrain from detailed discussions
of the genes mapping into suggestive regions. One locus that received some support through additional evidence is the one at
RSL24D1/UNC13C/RAB27A on chromosome 15 that showed
an association with proteinuria in CKD. This region was signiﬁcantly associated with a closely related phenotype, UACR, in
population-based data from the CKDGen Consortium.
The strengths of our study are the large international collection of patients and the careful and comprehensive phenotypic
characterization, including the availability of several renal function markers as well as measured GFR in a subset of the participants. Data cleaning and analysis were carried out using
state-of-the-art methods, which together with the public posting of the genotype data facilitates reproducibility and allows for
future pooling with data from additional cohorts. The consortium assembled data from understudied ethnicities such as the
Turkish population, where the Chronic Renal Disease in Turkey
(CREDIT) study estimated that the prevalence of pediatric
CKD stages 3–5 was 2600 per million age-related population
as opposed to 68.9 in Western Europe [48].
A number of limitations deserve acknowledgement. The
study did not have sufﬁcient statistical power to detect genetic
risk variants that confer only moderate changes in risk. As such,
it is not possible to draw deﬁnite conclusions about the presence of such variants, the genetic architecture of CKD in children when compared with adults or their effect on speciﬁc CKD
etiologies. Another important limitation is the lack of suitable
external replication cohorts. Finally, because of the study inclusion criteria, the full spectrum of eGFR could not be examined.
As the studies were designed with the objective to study CKD
progression, GWAS of kidney function decline and incident

end-stage renal disease should be performed once sufﬁcient
follow-up data have been collected.
In this ﬁrst GWAS meta-analysis of pediatric CKD, we did
not identify common genetic susceptibility variants signiﬁcantly associated with GFR, proteinuria or pediatric CKD status, although several suggestive candidates emerged. Even larger
efforts will be needed to draw reliable conclusions about the
presence of such variants in pediatric populations.
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A B S T R AC T
Background. Studies on the effectiveness of seasonal inﬂuenza vaccination in peritoneal dialysis (PD) patients are limited. The aim of the present study is to evaluate the
effectiveness of seasonal inﬂuenza vaccination in reducing
© The Author 2015. Published by Oxford University Press
on behalf of ERA-EDTA. All rights reserved.

morbidity and mortality in incident end-stage renal disease
patients on PD.
Methods. From Taiwan’s National Health Insurance Research
Database, we identiﬁed 2089 incident PD patients with seasonal inﬂuenza vaccination and 2089 propensity score
matched incident PD patients without the vaccination during
269

